First Robotic Cellular Resection Surgery in UAE Addresses Rare Tumor
Cleveland Clinic Abu Dhabi performs groundbreaking surgery with advanced technology to treat a low-grade mucinous tumor.
Cleveland Clinic Abu Dhabi has achieved a significant medical milestone by conducting the first cellular resection surgery using robotic assistance in the United Arab Emirates.
This pioneering procedure, combined with intraperitoneal heated chemotherapy, was employed to treat a rare low-grade mucinous tumor found in the appendix.
The surgery was performed on a 48-year-old female patient, during which a number of internal organs were removed in a bid to prevent the tumor from spreading within the abdominal cavity.
The surgical team was led by Dr. Yaser Akmal, a specialist in surgical oncology at the hospital’s Digestive Disease Institute, in collaboration with a group of renowned consultants within a multidisciplinary team.
This particular mucinous tumor is classified as rare, affecting less than 1% of cancer patients, and was incidentally discovered while performing an appendectomy.
Subsequent analyses revealed gelatinous material in the abdominal cavity, later confirmed to be a low-grade mucinous tumor, necessitating precise surgical intervention.
Given the advanced nature of the tumor, the medical team opted for a robotic-assisted cellular resection, followed by intraperitoneal chemotherapy at temperatures reaching 42 degrees Celsius for 90 minutes, aiming to eradicate any residual cancerous cells.
The use of robotic technology resulted in smaller surgical incisions, reduced pain, and expedited recovery for the patient, who was discharged from the hospital just five days post-surgery, compared to an average recovery time of two weeks for traditional surgeries.
Dr. George Pascal Habbal, CEO of Cleveland Clinic Abu Dhabi, remarked that this surgery signifies a groundbreaking advancement in robotic surgeries, asserting that the hospital will continue to expand its surgical innovations, aiming to minimize invasiveness while enhancing patient quality of life and therapeutic outcomes.
Additionally, Dr. Yaser Akmal noted that this surgical procedure exemplifies a combination of advanced technologies and rapid therapeutic approaches, emphasizing that this case represents a successful example of early intervention in life-saving measures and curtailing cancer proliferation.
This pioneering procedure, combined with intraperitoneal heated chemotherapy, was employed to treat a rare low-grade mucinous tumor found in the appendix.
The surgery was performed on a 48-year-old female patient, during which a number of internal organs were removed in a bid to prevent the tumor from spreading within the abdominal cavity.
The surgical team was led by Dr. Yaser Akmal, a specialist in surgical oncology at the hospital’s Digestive Disease Institute, in collaboration with a group of renowned consultants within a multidisciplinary team.
This particular mucinous tumor is classified as rare, affecting less than 1% of cancer patients, and was incidentally discovered while performing an appendectomy.
Subsequent analyses revealed gelatinous material in the abdominal cavity, later confirmed to be a low-grade mucinous tumor, necessitating precise surgical intervention.
Given the advanced nature of the tumor, the medical team opted for a robotic-assisted cellular resection, followed by intraperitoneal chemotherapy at temperatures reaching 42 degrees Celsius for 90 minutes, aiming to eradicate any residual cancerous cells.
The use of robotic technology resulted in smaller surgical incisions, reduced pain, and expedited recovery for the patient, who was discharged from the hospital just five days post-surgery, compared to an average recovery time of two weeks for traditional surgeries.
Dr. George Pascal Habbal, CEO of Cleveland Clinic Abu Dhabi, remarked that this surgery signifies a groundbreaking advancement in robotic surgeries, asserting that the hospital will continue to expand its surgical innovations, aiming to minimize invasiveness while enhancing patient quality of life and therapeutic outcomes.
Additionally, Dr. Yaser Akmal noted that this surgical procedure exemplifies a combination of advanced technologies and rapid therapeutic approaches, emphasizing that this case represents a successful example of early intervention in life-saving measures and curtailing cancer proliferation.
Translation:
Translated by AI
